Nature Communications (Nov 2019)

Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer

  • Naoki Nishio,
  • Nynke S. van den Berg,
  • Stan van Keulen,
  • Brock A. Martin,
  • Shayan Fakurnejad,
  • Nutte Teraphongphom,
  • Stefania U. Chirita,
  • Nicholas J. Oberhelman,
  • Guolan Lu,
  • Crista E. Horton,
  • Michael J. Kaplan,
  • Vasu Divi,
  • A. Dimitrios Colevas,
  • Eben L. Rosenthal

DOI
https://doi.org/10.1038/s41467-019-13076-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 10

Abstract

Read online

Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.